Relationships between highly recurrent tumor suppressor alterations in 489 leiomyosarcomas-Reference-Cited by-同舟云学术

Relationships between highly recurrent tumor suppressor alterations in 489 leiomyosarcomas

Published:2021-03-31 Issue:15 Volume:127 Page:2666-2673
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Schaefer Inga‐Marie¹^ORCID,Lundberg Meijun Z.¹,Demicco Elizabeth G.²³,Przybyl Joanna⁴,Matusiak Magdalena⁴,Chibon Frédéric⁵,Ingram Davis R.⁶⁷,Hornick Jason L.¹,Wang Wei‐Lien⁶⁷,Bauer Sebastian⁸⁹,Baker Laurence H.¹⁰,Lazar Alexander J.⁶⁷,Rijn Matt⁴,Mariño‐Enríquez Adrian¹,Fletcher Jonathan A.¹

Affiliation:

1. Department of Pathology Brigham and Women's HospitalHarvard Medical School Boston Massachusetts

2. Department of Pathology and Laboratory Medicine Sinai Health System Toronto Ontario Canada

3. Department of Laboratory Medicine and Pathobiology University of Toronto Toronto Ontario Canada

4. Department of Pathology Stanford University School of Medicine Stanford California

5. The Institut national de la santé et de la recherche médicale (INSERM) U1037, Cancer Research Center of Toulouse, Department of Pathology Claudius Régaud InstituteIUCT‐Oncopole Toulouse France

6. Department of Pathology The University of Texas MD Anderson Cancer Center Houston Texas

7. Department of Translational Molecular Pathology The University of Texas MD Anderson Cancer Center Houston Texas

8. Department of Medical Oncology, Sarcoma Center, West German Cancer Center University Duisburg‐Essen Medical School Essen Germany

9. Partner Site Essen and German Cancer Consortium Heidelberg Germany

10. Department of Internal Medicine University of Michigan Ann Arbor Michigan

Funder

National Cancer Institute

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.33542

Reference39 articles.

1. Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978–2001: An analysis of 26,758 cases

2. Incidence of soft tissue sarcoma and beyond

3. Prognosis and treatment of uterine leiomyosarcoma: A National Cancer Database study

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunohistochemical characteristics of uterine lipoleiomyomas;Pathology - Research and Practice;2024-08

2. Stathmin is an Independent Prognostic Marker of Poor Outcome in Uterine Leiomyosarcoma;International Journal of Gynecological Pathology;2024-06-04

3. Expanding the Spectrum of NR4A3 Fusion–Positive Gynecologic Leiomyosarcomas;Modern Pathology;2024-05

4. Molecular Heterogeneity in Leiomyosarcoma and Implications for Personalised Medicine;Current Treatment Options in Oncology;2024-04-24

5. Uterine Inflammatory Myofibroblastic Tumors;American Journal of Surgical Pathology;2024-04-17